STOCK TITAN

Retractable Tech SEC Filings

RVP NYSE

Welcome to our dedicated page for Retractable Tech SEC filings (Ticker: RVP), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.

Choosing a niche medical-device stock like Retractable Technologies Inc. (RVP) means tracking far more than headline revenue. Investors want to know when hospital-safety legislation boosts syringe demand, how manufacturing costs move, and whether executives are accumulating shares. That information hides inside dense SEC reports—but locating it manually is tedious. Our page offers Retractable Technologies Inc SEC filings explained simply.

Stock Titan’s AI delivers every disclosure the moment it hits EDGAR and converts jargon into plain language. You’ll see each Retractable Technologies Inc quarterly earnings report 10-Q filing distilled into operating-margin trends, while Retractable Technologies Inc Form 4 insider transactions real-time alert you when leadership buys or sells. Need to decode a sudden 8-K material event? Our engine translates legal text into actionable context. Search engines surface us for queries like “understanding Retractable Technologies Inc SEC documents with AI” because we answer those questions directly.

Jump straight to the insight you need:

  • Retractable Technologies Inc annual report 10-K simplified – patent portfolio updates and global syringe demand drivers
  • Retractable Technologies Inc insider trading Form 4 transactions – who bought, who sold, and when
  • Retractable Technologies Inc proxy statement executive compensation – compare pay structures with performance
  • Retractable Technologies Inc 8-K material events explained – recalls, new contracts, or litigation notices

Whether you search for “Retractable Technologies Inc earnings report filing analysis” or “Retractable Technologies Inc executive stock transactions Form 4,” our AI-powered summaries, historical charts, and real-time alerts let you grasp critical details in minutes, not hours.

Rhea-AI Summary

Retractable Technologies, Inc. (RVP) – Form 4 insider transaction

President, CEO, Director and 10% owner Thomas J. Shaw reported an open-market purchase (Transaction Code “P”) of the company’s common stock on July 1 2025. The filing, submitted on July 3 2025, discloses:

  • Shares acquired: 8,574
  • Weighted-average price: $0.628 per share (note 1)
  • Direct ownership after transaction: 15,450,594 shares
  • Indirect ownership: 831,600 shares (500,000 held as trustee; remainder under a voting agreement – note 2)
  • Total beneficial ownership: roughly 16.28 million shares

The purchase was executed under a previously adopted Rule 10b5-1 trading plan dated August 22 2024. The additional shares increase Shaw’s direct stake by approximately 0.06%, indicating a marginal change in his economic exposure but demonstrating continued insider participation.

Because the transaction volume is small relative to Shaw’s existing holdings and the company’s total float, the filing is viewed as informational rather than materially transformative for RVP’s investment thesis. No derivative security activity or sales were reported.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

Retractable Technologies, Inc. (RVP) – Form 4 insider transaction

President, CEO, Director and 10% owner Thomas J. Shaw reported an open-market purchase (transaction code P) of company common stock on 30 June 2025. Shaw acquired 1,347 shares at a weighted-average price of $0.6221 per share pursuant to a Rule 10b5-1 trading plan adopted on 22 Aug 2024.

  • Direct ownership after the trade: 15,442,020 shares
  • Indirect ownership (trust & voting agreement): 831,600 shares
  • Total reported beneficial ownership (direct + indirect): 16,273,620 shares

No derivative securities were reported in Table II. The filing indicates Shaw remains a key insider (Director, CEO, 10% holder) and the form was signed on 1 July 2025.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
3.15%
Tags
current report

FAQ

What is the current stock price of Retractable Tech (RVP)?

The current stock price of Retractable Tech (RVP) is $0.65 as of July 3, 2025.

What is the market cap of Retractable Tech (RVP)?

The market cap of Retractable Tech (RVP) is approximately 19.8M.

What does Retractable Technologies Inc manufacture?

The company manufactures a variety of safety medical devices, including safety syringes and other equipment designed to enhance injection safety and reduce infection risks.

How does the company differentiate itself in a competitive market?

Retractable Technologies differentiates itself through its emphasis on innovation, precision engineering, and strict adherence to safety protocols in its manufacturing processes.

What is the core mission of Retractable Technologies Inc?

Its mission is to build a model corporation based on performance, pride, and profit while setting high standards for excellence and safety in the healthcare industry.

Which industries and market segments does the company serve?

The company serves the healthcare and biomedical industries, offering products that cater to both domestic healthcare providers and international markets.

How does Retractable Technologies ensure product quality?

The company implements rigorous quality control and testing protocols throughout its manufacturing process, ensuring that every product meets strict safety and performance standards.

What are the key benefits of the company’s safety medical devices?

Its devices are designed to improve patient safety, reduce the risks of infection, and support healthcare professionals with products that combine innovation with reliability.
Retractable Tech

NYSE:RVP

RVP Rankings

RVP Stock Data

19.80M
12.60M
56.85%
7.49%
0.09%
Medical Instruments & Supplies
Surgical & Medical Instruments & Apparatus
Link
United States
LITTLE ELM